PNoy, 19 pa kinasuhan kaugnay ng Dengvaxia

February 12,2018
share this

PNoy, 19 pa kinasuhan kaugnay ng Dengvaxia

February 12,2018
share this

SINAMPAHAN si dating pangulong Benigno “Noynoy” Aquino III at 19 na iba pa ng patong-patong na kaso sa Department of Justoce (DOJ) kaugnay ng pagkamatay ng mga batang nabakunahan ng Dengvaxia.
Bukod kay Aquino, kabilang sa kinasuhan ng multiple homicide at physical injuries through negligence ng Volunteers Against Crime and Corruption (VACC) at Vanguard of the Philippine Constitution Inc. (VPCI) ay sina dating Budget secretary Florencio Abad at datin Health secretary Janette Garin.
Kabilang din sa mga kinasuhan ay sina incumbent DOH undersecretaries Carol Tanio, Gerardo Bayugo, Lilibeth David and Mario Villaverde; former retired undersecretaries Nemesio Gako, Vicente Belizario Jr. at Kenneth Hartigan-Go; assistant secretaries Lyndon Lee Suy at Nestor Santiago; dating financial management service director Laureano Cruz; incumbent DOH directors Joyce Ducusin, May Wynn Belo, Leonila Gorgolon, Rio Magpantay, Ariel Valencia at Julius Lecciones; dating executive assistant ni Garin na si Yolanda Oliveros.

Kinasuhan din ang mga senior executives ng French pharmaceutical firm na Sanofi Pasteur, ang developer at manufacturer ng Dengvaxia; at Selling Pharma, ang supplier ng vaccine.

“Since correlation between vaccine (Dengvaxia) and deaths have been established prima facie, respondents Aquino III, Abad, Garin and the other respondents should stand trial for criminal negligence,” sabi ni Atty. Manuelito Luna, abogado ng VACC.

“The respondents should be charged with multiple homicide and physical injuries through criminal negligence,” ayon pa kay Luna.

Samantala, sinabi naman ng kampo ni Aquino na nakahanda ang dating presidente na harapin ang kaso laban sa kanya.
“Former President Aquino is prepared to answer the baseless allegations made against him,” sabi ni Atty. Abigail Valte, tagapagsalita ni Aquino.

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Bandera. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TODAY'S ISSUE OF BANDERA
What's trending